Legendary creatures are reportedly considering a second listing outside of the United States, with possible listing locations including Hong Kong.

Insiders say that due to strong interest from investors in pharmaceutical companies, Legend Biotech is considering a secondary listing outside of the United States. Insiders suggest possible listing locations could include Hong Kong, Singapore, and London. However, the decision on a second listing is still under consideration and Legend Biotech may ultimately decide against it. A representative from Legend Biotech declined to comment.